471 related articles for article (PubMed ID: 16849428)
21. Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance.
Meirelles K; Benedict LA; Dombkowski D; Pepin D; Preffer FI; Teixeira J; Tanwar PS; Young RH; MacLaughlin DT; Donahoe PK; Wei X
Proc Natl Acad Sci U S A; 2012 Feb; 109(7):2358-63. PubMed ID: 22308459
[TBL] [Abstract][Full Text] [Related]
22. Antibody against avian müllerian inhibiting substance (MIS) recognizes MIS on rat müllerian duct and human tumor cells.
Wang JJ; Teng CS
Proc Natl Sci Counc Repub China B; 1989 Oct; 13(4):267-75. PubMed ID: 2484046
[TBL] [Abstract][Full Text] [Related]
23. Mullerian inhibiting substance inhibits ovarian cell growth through an Rb-independent mechanism.
Ha TU; Segev DL; Barbie D; Masiakos PT; Tran TT; Dombkowski D; Glander M; Clarke TR; Lorenzo HK; Donahoe PK; Maheswaran S
J Biol Chem; 2000 Nov; 275(47):37101-9. PubMed ID: 10958795
[TBL] [Abstract][Full Text] [Related]
24. Mullerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo.
Segev DL; Hoshiya Y; Hoshiya M; Tran TT; Carey JL; Stephen AE; MacLaughlin DT; Donahoe PK; Maheswaran S
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):239-44. PubMed ID: 11773638
[TBL] [Abstract][Full Text] [Related]
25. Identification of cancer stem-like side population cells in ovarian cancer cell line OVCAR-3.
Gao Q; Geng L; Kvalheim G; Gaudernack G; Suo Z
Ultrastruct Pathol; 2009; 33(4):175-81. PubMed ID: 19728235
[TBL] [Abstract][Full Text] [Related]
26. Side populations of gastrointestinal cancers are not enriched in stem cells.
Burkert J; Otto WR; Wright NA
J Pathol; 2008 Apr; 214(5):564-73. PubMed ID: 18266310
[TBL] [Abstract][Full Text] [Related]
27. Recombinant human mullerian inhibiting substance inhibits human ocular melanoma cell lines in vitro and in vivo.
Parry RL; Chin TW; Epstein J; Hudson PL; Powell DM; Donahoe PK
Cancer Res; 1992 Mar; 52(5):1182-6. PubMed ID: 1531323
[TBL] [Abstract][Full Text] [Related]
28. Mullerian inhibiting substance inhibits breast cancer cell growth through an NFkappa B-mediated pathway.
Segev DL; Ha TU; Tran TT; Kenneally M; Harkin P; Jung M; MacLaughlin DT; Donahoe PK; Maheswaran S
J Biol Chem; 2000 Sep; 275(37):28371-9. PubMed ID: 10874041
[TBL] [Abstract][Full Text] [Related]
29. Müllerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers.
Bakkum-Gamez JN; Aletti G; Lewis KA; Keeney GL; Thomas BM; Navarro-Teulon I; Cliby WA
Gynecol Oncol; 2008 Jan; 108(1):141-8. PubMed ID: 17988723
[TBL] [Abstract][Full Text] [Related]
30. Mullerian inhibiting substance reduction of colony growth of human gynecologic cancers in a stem cell assay.
Fuller AF; Krane IM; Budzik GP; Donahoe PK
Gynecol Oncol; 1985 Oct; 22(2):135-48. PubMed ID: 3932140
[TBL] [Abstract][Full Text] [Related]
31. A preliminary study of side population cells in human gastric cancer cell line HGC-27.
Gao G; Sun Z; Wenyong L; Dongxia Y; Zhao R; Zhang X
Ann Transplant; 2015 Mar; 20():147-53. PubMed ID: 25773762
[TBL] [Abstract][Full Text] [Related]
32. Mullerian Inhibiting Substance induces NFkB signaling in breast and prostate cancer cells.
Hoshiya Y; Gupta V; Segev DL; Hoshiya M; Carey JL; Sasur LM; Tran TT; Ha TU; Maheswaran S
Mol Cell Endocrinol; 2003 Dec; 211(1-2):43-9. PubMed ID: 14656475
[TBL] [Abstract][Full Text] [Related]
33. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
[TBL] [Abstract][Full Text] [Related]
34. The Anti-Mullerian hormone and ovarian cancer.
La Marca A; Volpe A
Hum Reprod Update; 2007; 13(3):265-73. PubMed ID: 17213257
[TBL] [Abstract][Full Text] [Related]
35. Replacing Hoechst33342 with rhodamine123 in isolation of cancer stem-like cells from the MHCC97 cell line.
Liu WH; Qian NS; Li R; Dou KF
Toxicol In Vitro; 2010 Mar; 24(2):538-45. PubMed ID: 19913610
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of the fetal stem cell factor SOX17 by H33342: a mechanism responsible for differential gene expression in breast cancer side population cells.
Christgen M; Geffers R; Ballmaier M; Christgen H; Poczkaj J; Krech T; Kreipe H; Lehmann U
J Biol Chem; 2010 Feb; 285(9):6412-8. PubMed ID: 20040597
[TBL] [Abstract][Full Text] [Related]
37. Ovarian cancer stem cells.
Zeimet AG; Reimer D; Sopper S; Boesch M; Martowicz A; Roessler J; Wiedemair AM; Rumpold H; Untergasser G; Concin N; Hofstetter G; Muller-Holzner E; Fiegl H; Marth C; Wolf D; Pesta M; Hatina J
Neoplasma; 2012; 59(6):747-55. PubMed ID: 22862176
[TBL] [Abstract][Full Text] [Related]
38. Identification of side population cells (stem-like cell population) in pediatric solid tumor cell lines.
Komuro H; Saihara R; Shinya M; Takita J; Kaneko S; Kaneko M; Hayashi Y
J Pediatr Surg; 2007 Dec; 42(12):2040-5. PubMed ID: 18082704
[TBL] [Abstract][Full Text] [Related]
39. Ovarian granulosa cell tumors express a functional membrane receptor for anti-Müllerian hormone in transgenic mice.
Dutertre M; Gouédard L; Xavier F; Long WQ; di Clemente N; Picard JY; Rey R
Endocrinology; 2001 Sep; 142(9):4040-6. PubMed ID: 11517183
[TBL] [Abstract][Full Text] [Related]
40. Possible association between stem-like hallmark and radioresistance in human cervical carcinoma cells.
Kumazawa S; Kajiyama H; Umezu T; Mizuno M; Suzuki S; Yamamoto E; Mitsui H; Sekiya R; Shibata K; Kikkawa F
J Obstet Gynaecol Res; 2014 May; 40(5):1389-98. PubMed ID: 24750491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
